NCT02655029已完成不适用
Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension
Servier Hellas Pharmaceuticals Ltd.1 个研究点 分布在 1 个国家目标入组 2,285 人开始时间: 2015年11月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,285
- 试验地点
- 1
- 主要终点
- Adherence to treatment
研究概览
简要总结
The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.
详细描述
This is a non-interventional study aiming to record adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels will be recorded, as well as safety and tolerability of this fixed dose combination.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female, ambulatory patients >18 years old.
- •Clinically diagnosed essential arterial hypertension.
- •Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.
- •The patient has given his/her written consent after being informed, before his inclusion in the study.
排除标准
- •Secondary arterial hypertension.
- •Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event with serious residual lesions, scheduled procedure or surgical operation or hospital admission.
- •Pregnancy, lactation or intention to become pregnant.
结局指标
主要结局
Adherence to treatment
时间窗: Change of total score of compliance scale between baseline and 1st month and between 1st and 4th month of treatment
Total score of Hill-Bone High Blood Pressure Compliance Scale will be recorded at each study visit
次要结局
- Diastolic Blood Pressure(All visits (baseline, 1st and 4th month of treatment))
- Systolic Blood Pressure(All visits (baseline, 1st and 4th month of treatment))
- Adverse events recording leading to treatment discontinuation(1st and 4th month of treatment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B PatientsHepatitis B, ChronicNCT01356901Bristol-Myers Squibb230
已完成
不适用
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment AdherenceBreast CancerNCT01081509AstraZeneca1,077
已完成
不适用
This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive BladderOveractive BladderNCT00943735Pfizer774
终止
不适用
Study of Diroximel Fumarate in the Real-World SettingRelapsing Forms of MSNCT04746976Biogen75
终止
不适用
Exploring Diroximel Fumarate Real-world Experience in Canada and IsraelRelapsing Forms of MSNCT04948606Biogen64